Finance

Lists
GMED:BMV
Globus Medical Inc
MX$1,390.45
0.00%
(0.00) 1D
Jul 16, 12:56:01 PM GMT-6  ·   MXN
All symbols
SymbolPriceChange% Change
Generating top insights for GMED...
Mkt. cap
10.51B
Avg. vol.
27.00
Volume
0.00
52-wk high
MX$1,670.00
52-wk low
MX$1,067.00
Shares outstanding
76.02M
No. of employees
6K
Mkt. cap
10.51B
Avg. vol.
27.00
Volume
0.00
52-wk high
MX$1,670.00
52-wk low
MX$1,067.00
Shares outstanding
76.02M
No. of employees
6K
Profile
Globus Medical, Inc. is a publicly traded orthopedic medical device company headquartered in Audubon, Pennsylvania, United States. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders. Wikipedia
About Globus Medical Inc
CEOKeith Pfeil
Employees6K
Founded2003
Headquarters-
SectorMedical device
Websiteglobusmedical.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
769.05M
826.42M
759.85M
789.61M
Cost of goods sold
246.13M
254.62M
234.07M
241.44M
Cost of revenue
246.13M
254.62M
234.07M
241.44M
Research and development expenses
38.07M
36.16M
36.51M
36.32M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
284.19M
304.78M
297.77M
286.82M
Operating expense
352.10M
370.30M
363.81M
352.70M
Total operating expenses
598.23M
624.93M
597.87M
594.14M
Operating income
170.82M
201.49M
161.98M
195.47M
Other non operating income
1.54M
865.00K
2.25M
1.17M
EBT including unusual items
143.99M
169.23M
157.07M
189.82M
EBT excluding unusual items
173.65M
198.52M
167.55M
202.85M
Income tax expense
25.03M
28.64M
32.77M
38.25M
Effective tax rate
17.38%
16.92%
20.86%
20.15%
Other operating expenses
-
-
-
-
Net income
118.97M
140.59M
124.30M
151.57M
Net profit margin
15.47%
17.01%
16.36%
19.20%
Earnings per share
1.18
1.28
1.12
1.34
Interest and investment income
1.46M
3.31M
5.43M
7.07M
Interest expense
-
-
-
-
Net interest expenses
1.46M
3.31M
5.43M
7.07M
Depreciation and amortization charges
-
-
-
-
EBITDA
242.02M
270.31M
231.93M
265.05M
Gain or loss from assets sale
2.31M
4.09M
2.45M
3.11M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps